Related references
Note: Only part of the references are listed.GBD 2016 Meningitis Collaborators. Global, regional, and national burden of meningitis, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 (vol 17, pg 1061, 2018)
Mohsen Naghavi
LANCET NEUROLOGY (2021)
Invasive Meningococcal Disease in Africa's Meningitis Belt: More Than Just Meningitis?
Heather E. Reese et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Cost Effectiveness of Meningococcal Serogroup B Vaccination in College-Aged Young Adults
Ira L. Leeds et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2019)
A SYSTEMATIC REVIEW: COST-EFFECTIVENESS OF VACCINATION WITH NEW MENINGOCOCCAL SEROGROUP B VACCINES
R. Smit
VALUE IN HEALTH (2018)
Invasive Meningococcal Disease in the Vaccine Era
Simon Nadel et al.
FRONTIERS IN PEDIATRICS (2018)
Impact of MenAfriVac in nine countries of the African meningitis belt, 2010-15: an analysis of surveillance data
Caroline L. Trotter et al.
LANCET INFECTIOUS DISEASES (2017)
Modelling the cost-effectiveness of catch-up 'MenB' (Bexsero) vaccination in England
Hannah Christensen et al.
VACCINE (2017)
Enter B and W: two new meningococcal vaccine programmes launched
Shamez N. Ladhani et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2016)
Cost-utility analysis of a nationwide vaccination programme against serogroup B meningococcal disease in Israel
Gary M. Ginsberg et al.
INTERNATIONAL JOURNAL OF PUBLIC HEALTH (2016)
Epidemiological impact and cost-effectiveness of universal vaccination with Bexsero® to reduce meningococcal group B disease in Germany
Hannah Christensen et al.
VACCINE (2016)
Epidemiological impact and cost-effectiveness of introducing vaccination against serogroup B meningococcal disease in France
Heloise Lecocq et al.
VACCINE (2016)
How to prepare a systematic review of economic evaluations for clinical practice guidelines: database selection and search strategy development (part 2/3)
F. W. Thielen et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2016)
How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: a five-step approach (part 1/3)
Ghislaine A. P. G. van Mastrigt et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2016)
Economic evaluation of vaccines in Canada: A systematic review
Ayman Chit et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Vaccinating Italian infants with a new multicomponent vaccine (Bexsero (R)) against meningococcal B disease: A cost-effectiveness analysis
Roberto Gasparini et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Meningococcal B vaccination: real-world experience and future perspectives
Parvane Kuhdari et al.
PATHOGENS AND GLOBAL HEALTH (2016)
The multicomponent meningococcal serogroup B vaccine (4CMenB): origin, composition, health impact and unknown aspects
Chiara Mameli et al.
FUTURE MICROBIOLOGY (2015)
Meningococcal vaccines: Current state and future outlook
M. Leca et al.
PATHOLOGIE BIOLOGIE (2015)
Cost-effectiveness analysis of a multicomponent meningococcal serogroup B vaccine in hypothetic epidemic situation in a middle-income country
Giannina Izquierdo et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices, 2015
Jessica R. MacNeil et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2015)
Health and Economic Outcomes of Introducing the New MenB Vaccine (Bexsero) into the Italian Routine Infant Immunisation Programme
Marcello Tirani et al.
PLOS ONE (2015)
Advances towards the prevention of meningococcal B disease: A multidimensional story
Marion Roderick et al.
JOURNAL OF INFECTION (2014)
Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial
Robert C. Read et al.
LANCET (2014)
Economic evaluation of meningococcal serogroup B childhood vaccination in Ontario, Canada
Hong Anh T. Tu et al.
VACCINE (2014)
Distribution of invasive meningococcal B disease in Italian pediatric population: Implications for vaccination timing
Chiara Azzari et al.
VACCINE (2014)
Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study
Hannah Christensen et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose
Matthew D. Snape et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2013)
Immunisation against meningococcus B
Rino Rappuoli
LANCET (2013)
Bactericidal Antibody Persistence 2 Years After Immunization With 2 Investigational Serogroup B Meningococcal Vaccines at 6, 8 and 12 Months and Immunogenicity of Preschool Booster Doses A Follow-on Study to a Randomized Clinical Trial
Matthew D. Snape et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)
Introducing vaccination against serogroup B meningococcal disease: An economic and mathematical modelling study of potential impact
Hannah Christensen et al.
VACCINE (2013)
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)-Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force
Don Husereau et al.
VALUE IN HEALTH (2013)
Cost-effectiveness of vaccination against meningococcal B among Dutch infants Crucial impact of changes in incidence
Koen B. Pouwels et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
Don Husereau et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2013)
Dynamic Transmission Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-5
Richard Pitman et al.
MEDICAL DECISION MAKING (2012)
The changing and dynamic epidemiology of meningococcal disease
Scott A. Halperin et al.
VACCINE (2012)
Molecular typing methods for outbreak detection and surveillance of invasive disease caused by Neisseria meningitidis, Haemophilus influenzae and Streptococcus pneumoniae, a review
Odile B. Harrison et al.
MICROBIOLOGY-SGM (2011)
Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease
Darryl J. Hill et al.
CLINICAL SCIENCE (2010)
Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis
Karen Edmond et al.
LANCET INFECTIOUS DISEASES (2010)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
Alessandro Liberati et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Global epidemiology of meningococcal disease
Lee H. Harrison et al.
VACCINE (2009)
Optimal search strategies for detecting health services research studies in MEDLINE
NL Wilczynski et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2004)
Share Paper
